Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiotropium Respimat in Severe Persistent Asthma
NCT00365560Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Aug 2006
- Primary completion
- Nov 2007
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 2, randomised, double-blind trial of tiotropium in asthma (3 arms), sponsored by Boehringer Ingelheim. Primary endpoint: Peak Forced Expiratory Volume in 1 second at 8 weeks. Started Aug 2006; status: completed.
02
Drugs
tiotropium
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00365560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00365560.